# Phase 5A — UDS clinical evidence table

Local implementation checkpoint: `b43a5b38e6b60070dd4f2ffedb1369c0b63832a2`;
tree `6a9558a468dec3e2a8d979eefd7fe21954742afe`.

The results use a native table with column and row headers, full analyte names,
physical position and canonical panel codes. Negative results are neutral;
preliminary positive and invalid results keep explicit text/flags and exceptional
emphasis. Exact panel order, entry cycle, direct keys, roving focus, bulk actions,
presumptive status, QC, storage/lock and note builders are unchanged.

The dedicated UDS screen stylesheet replaces the retired lab grid/result rules
and duplicate Tebra state styling. Injection's separate MAR grid stays unchanged.
Visual inspection caught wrapped Flag/INV text and an old count overlay; the flag
column now fits its text and counts follow the table without covering a result.

Preservation, type/static and build passed. **14 unique targeted cases passed**,
retries=0, including four wide/narrow Compact/Comfortable native table/order/key/focus
cases with forced colors and last-analyte reachability; normal QC/cycling, 13-panel
omission, custom-device completion, exact note copy across all workflows, UDS save/
resume, signature time, lock/addendum, remount and locked printing.

Two initial clipboard checks lacked native permissions on the fresh scratch preview
origin. Granting the same clipboard permissions to that origin resolved them;
the final combined fourteen-case run passed using the native Clipboard API.
No committed clipboard test assertion changed.

Reviewed eight synthetic table screenshots at 1440x900 and 800x600 in both densities,
including last-row keyboard focus. Also reviewed the final narrow states after
removing the count overlay: NEG / POS* / INV!, flags and statuses are fully legible.
No visual references or tolerances changed here. Full final certification remains
Phase 6; this targeted phase gate is green.
